Akari Therapeutics PLC (AKTX)
NASDAQ NMS - GLOBAL MARKET · Biotechnology
$8.43-0.03 (-0.35%)Quote refreshed
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Market Cap
$9.7M
P/E (TTM)
—
EPS
—
Div Yield
—
52W Range
—
Beta
—
Company overview
No company overview is available for Akari Therapeutics PLC yet.
Peers in Biotechnology
All in industry →VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%
Recent press releases
Akari Therapeutics PLC has not issued a press release in this window.
SEC filings
All filings →Akari Therapeutics PLC has not filed an SEC document in this window.
Insider trades
All insider trades →Akari Therapeutics PLC has no reported insider trades in the last 90 days.
Institutional holders
All holders →As of 2025-12-31 · prior 2025-09-30
ARMISTICE CAPITAL, LLC$787,226
2,723,966 sh● NEW
Cresset Asset Management, LLC$237,693
822,468 sh0.0%
Palo Alto Investors LP$42,201
146,024 sh0.0%
Warberg Asset Management LLC$88,709
308,340 sh● NEW
HighTower Advisors, LLC$22,899
79,236 sh0.0%
JANE STREET GROUP, LLC$20,705
71,644 sh● NEW
SmartHarvest Portfolios, LLC$20,013
69,248 sh● NEW
Cerity Partners LLC$6,833
23,643 sh0.0%
People at Akari Therapeutics PLC
All people →Quarterly financials
Full financials →Revenue trend
03/25
—
NI -$3.7M
06/25
—
NI -$1.9M
09/25
—
NI -$6.4M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $0.00
Prior: $0.00
Revenue sparkline